Allogene Therapeutics(ALLO) - 2025 Q1 - Earnings Call Transcript

Allogene Therapeutics (ALLO) Q1 2025 Earnings Call May 13, 2025 05:00 PM ET Company Participants Christine Cassiano - Executive VP, Chief Corporate Affairs & Brand Strategy OfficerDavid Chang - Co-Founder, President, CEO & DirectorZachary Roberts - Executive VP of Research & Development and Chief Medical OfficerGeoffrey Parker - Executive VP & CFOMichael Yee - Managing DirectorMatthew Biegler - Managing DirectorSamantha Semenkow - Vice PresidentReni Benjamin - Managing DirectorCaleb Stubbs - Biotechnology E ...